Prostanoids, but not nitric oxide, counterregulate angiotensin II mediated vasoconstriction in vivo
- 13 September 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 428 (3) , 331-336
- https://doi.org/10.1016/s0014-2999(01)01349-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive PatientsHypertension, 2000
- Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal FunctionHypertension, 2000
- Action of AT1 receptor antagonists on angiotensin II‐induced tone in human isolated subcutaneous resistance arteriesBritish Journal of Pharmacology, 1999
- Angiotensin II Stimulates Synthesis of Endothelial Nitric Oxide SynthaseHypertension, 1998
- The Role of Basally Synthesized Nitric Oxide in Modulating the Renal Vasoconstrictor Action of Angiotensin II.Hypertension Research, 1997
- Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal HemodynamicsHypertension, 1996
- Endothelial AT 1 –Mediated Release of Nitric Oxide Decreases Angiotensin II Contractions in Rat Carotid ArteryHypertension, 1995
- Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in miceNature, 1995
- Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant ratsBritish Journal of Pharmacology, 1993
- Resistance of the renal biosynthesis of prostaglandin E2 to the inhibitory effect of indomethacin in the rat in vivoProstaglandins, Leukotrienes & Essential Fatty Acids, 1990